155 related articles for article (PubMed ID: 32835735)
1. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer.
Uzzaman A; Zhang X; Qiao Z; Zhan H; Sohail A; Wahid A; Shang Z; Guan X; Cao CX; Xiao H
Biochimie; 2020 Oct; 177():132-141. PubMed ID: 32835735
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of small extracellular vesicles from the plasma of patients with hepatocellular carcinoma.
Dong W; Xia Z; Chai Z; Qiu Z; Wang X; Yang Z; Wang J; Zhang T; Zhang Q; Jin J
World J Surg Oncol; 2022 Dec; 20(1):387. PubMed ID: 36471393
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
[TBL] [Abstract][Full Text] [Related]
4. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
Saito Y; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
Oncol Rep; 2010 May; 23(5):1325-30. PubMed ID: 20372847
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
[TBL] [Abstract][Full Text] [Related]
6. NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis.
Liu Y; Hong Z; Tan G; Dong X; Yang G; Zhao L; Chen X; Zhu Z; Lou Z; Qian B; Zhang G; Chai Y
Int J Cancer; 2014 Aug; 135(3):658-68. PubMed ID: 24382646
[TBL] [Abstract][Full Text] [Related]
7. A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease.
Gray J; Chattopadhyay D; Beale GS; Patman GL; Miele L; King BP; Stewart S; Hudson M; Day CP; Manas DM; Reeves HL
BMC Cancer; 2009 Aug; 9():271. PubMed ID: 19656391
[TBL] [Abstract][Full Text] [Related]
8. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
9. Identification of human hepatocellular carcinoma-related proteins by proteomic approaches.
Yang MH; Tyan YC; Jong SB; Huang YF; Liao PC; Wang MC
Anal Bioanal Chem; 2007 Jun; 388(3):637-43. PubMed ID: 17447055
[TBL] [Abstract][Full Text] [Related]
10. Activity of serum angiotensin-converting enzyme as a tumour marker of hepatocellular carcinoma.
Kardum D; Huskic J; Fabijanic D; Banic M; Buljevac M; Kujundzic M; Loncar B
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1209-13. PubMed ID: 10563528
[TBL] [Abstract][Full Text] [Related]
11. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
Cui J; Kang X; Dai Z; Huang C; Zhou H; Guo K; Li Y; Zhang Y; Sun R; Chen J; Li Y; Tang Z; Uemura T; Liu Y
J Cancer Res Clin Oncol; 2007 Nov; 133(11):825-34. PubMed ID: 17516088
[TBL] [Abstract][Full Text] [Related]
12. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
[No Abstract] [Full Text] [Related]
13. Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.
Han J; Han ML; Xing H; Li ZL; Yuan DY; Wu H; Zhang H; Wang MD; Li C; Liang L; Song YY; Xu AJ; Wu MC; Shen F; Xie Y; Yang T
Int J Cancer; 2020 Mar; 146(6):1741-1753. PubMed ID: 31361910
[TBL] [Abstract][Full Text] [Related]
14. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography-mass spectrometry.
Passos-Castilho AM; Carvalho VM; Cardozo KH; Kikuchi L; Chagas AL; Gomes-Gouvêa MS; Malta F; de Seixas-Santos Nastri AC; Pinho JR; Carrilho FJ; Granato CF
BMC Cancer; 2015 Dec; 15():985. PubMed ID: 26680993
[TBL] [Abstract][Full Text] [Related]
15. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
16. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
[TBL] [Abstract][Full Text] [Related]
17. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis accuracy of serum Glypican-3 level in patients with hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
Liu JW; Zuo XL; Wang S
Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3655-73. PubMed ID: 26502856
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma.
Barsoum I; Elgohary MN; Bassiony MAA
Cancer Biomark; 2020; 28(4):523-528. PubMed ID: 32568173
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cirrhosis and hepatocellular carcinoma using low-angle x-ray scattering signatures of serum.
Elshemey WM; Desouky OS; Mohammed MS; Elsayed AA; el-Houseini ME
Phys Med Biol; 2003 Sep; 48(17):N239-46. PubMed ID: 14516110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
